The current options for monitoring the course of solid tumors are essentially limited to imaging methods and conventional markers. The sensitivity and specificity of computer tomography and the measurement of carcinoembryonic antigen in the blood are limited in colorectal cancer (colon cancer). Thus, a therapeutic consequence can often only be drawn in the case of a disease or progression that can be clinically or morphologically ascertained.
The development and preproduction of an inexpensive and easy-to-use functional sample of a detection platform based on digital PCR (dPCR) with integrated sample preparation for early therapy optimization and treatment of colorectal cancer.
Digital camera-based detection system and software of a processing device for the automation of routine clinical diagnosis of circulating tumor DNA
Bioron GmbH, Ludwigshafen
velixX GmbH, Mannheim
TDC GmbH, Mannheim
Universitätsklinikum Freiburg
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V., Freiburg
ARTUR – Automatisierungsplattform zur Routineanalyse zirkulierender Tumor DNA mittels digitaler PCR – is sponsored by Bundesministerium für Forschung und Entwicklung
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
